Table 2. Anthropometric variables and serum lipid levels of the study population, median (IQR) or n (%).
| Variables | Total (n = 3797) | Rural (n = 918) | Urban (n = 2879) | p-value |
|---|---|---|---|---|
| FBS | 5.39 (4.72–7.81) | 6.61 (5.01–9.25) | 5.21 (4.67–7.33) | < 0.001 |
| Type 2 Diabetes | 1507(39.7) | 513(55.9) | 994(34.5) | < 0.001 |
| Pre-diabetes | 924(24.3) | 340(37.0) | 584(20.3) | < 0.001 |
| Hypertention | 1317(34.7) | 397(43.4) | 920(32.0) | < 0.001 |
| SBP (mmHg) | 122 (111–130) | 124 (115–130) | 121 (110–130) | < 0.001 |
| DBP (mmHg) | 83 (70–90) | 85 (72–92.5) | 82 (70–90) | < 0.001 |
| Weight (Kg) | 76(67–84) | 75(66–84) | 76.5 (68–83.5) | 0.239 |
| Height (cm) | 168(163–172) | 168(162–173) | 168 (163–172) | 0.922 |
| BMI (Kg/m2) | 26.47 (24.27–29.05) | 26.44 (23.99–29.29) | 26.53 (24.39–29.03) | 0.229 |
| Obesity (BMI ≥ 28 Kg/m2) | 1283(33.9) | 311(33.9) | 972(33.8) | 0.985 |
| WC | 95.0 (88.5–102) | 96 (88–104) | 95 (88.5–102.0) | 0.067 |
| HC | 100.0 (85.0–108.0) | 102 (93–110) | 103.00 (95–109.00) | < 0.001 |
| WHR | 0.94 (0.89–1.07) | 0.93 (0.89–1.01) | 0.95 (0.88–1.11) | < 0.001 |
| Hperlipidemia | 2957(77.0) | 780(85.0) | 2177(75.6) | < 0.001 |
| TC (mmol/l) | 4.31 (2.95–5.12) | 4.2 (2.76–5.05) | 4.34 (3.04–5.15) | 0.078 |
| TG (mmol/l) | 1.93 (1.17–4.03) | 2.05 (1.27–4.13) | 1.85 (1.13–3.94) | < 0.001 |
| HDL-c (mmol/l) | 1.12 (0.92–1.34) | 1.03 (0.83–1.26) | 1.15 (0.95–1.36 | < 0.001 |
| LDL-c (mmol/l) | 2.77 (2.31–3.32) | 2.78 (2.26–3.32) | 2.77 (2.33–3.32) | 0.705 |
Data is presented as median (IQR) or n (%); Chi-square or Fisher’s test. p < 0.05 was considered significant difference. IQR: Interquartile range, BMI: Body Mass Index, WC: Waist Circumference, HC: Hip Circumference, WHR: Waist to Hip Ratio, TC: Total Cholesterol, TG: Triglycerides, HDL-c: High Density Lipoprotein cholesterol, LDL-c: Low Density Lipoprotein cholesterol.